A reply to Rocky on IHub: Thanks Rocky, very go

A reply to Rocky on IHub:

Thanks Rocky, very good article. Last Wednesday evening I attended a medical conference on treating chronic pain. When the speaker asked the physicians in attendance what steps they take before prescribing opioids/narcotics, one physician stated he uses compounding creams and has seen very good results. The fear of prescribing opioids along with the DEA regulations and monitoring has led to pain specialists resorting to other less addictive modes of therapy. I know several plastic surgeons who like compounding creams to prevent scarring, but the multi-billion dollar chronic pain market could provide a huge opportunity for the compounding pharmacy market. SCRC has positioned itself very nicely to capture a sizable portion of this market place. With six straight months of growth, it is apparent Mr. Schneiderman is doing something right. I would hope he is working on other opportunities to expand the growth potential in this market place. With five other revenue streams contributing to the bottom line, SCRC is gaining serious momentum in becoming a financial powerhouse. I look forward to the results in the months to follow.